PTG 020
Alternative Names: PTG-020Latest Information Update: 19 Apr 2024
At a glance
- Originator PolTREG
- Class Gene therapies; Regulatory T lymphocyte cell therapies
- Mechanism of Action Regulatory T-lymphocyte replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Type 1 diabetes mellitus
Most Recent Events
- 27 Mar 2024 Early research in Type 1 diabetes mellitus in Poland (Parenteral) (POLTREG pipeline; March 2024)